BUSINESS
Once-Monthly Injectable Abilify Reduces Total Psychiatric Hospitalization Rates following Disease Relapse: Otsuka, Lundbeck
Otsuka Pharmaceutical and H. Lundbeck A/S of Denmark announced on May 22 that the once-monthly injectable treatment Abilify Maintena (aripiprazole) demonstrated a statistically significant reduction in total psychiatric hospitalization rates for schizophrenia patients previously taking oral antipsychotics who were switched…
To read the full story
BUSINESS
- Novartis Overhauls Sales Model to Prioritize Solving Regional Treatment Gaps
November 14, 2025
- Keytruda Again Tops Japan Market in July-September: IQVIA
November 14, 2025
- UK Clears Monthly IV Maintenance Dosing for Leqembi: Eisai/Biogen
November 14, 2025
- Kaken Gets Select-Asia Rights to Numab’s Multi-Specific Antibody
November 14, 2025
- Pluvicto, Imaavy, Hernexeos Now Available in Japan
November 13, 2025
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…





